Market News AIOpen the app

AIM stock news · AIM ImmunoTech Inc.

Stories about AIM ImmunoTech Inc. (AIM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AIM

Follow AIM ImmunoTech Inc. (AIM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AIM
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 9:32 AM ET · Market

    AIM ImmunoTech shared new details about its product Ampligen in a recent filing.

    Neutral

    AIM filed an SEC report listing a company presentation and a Nov. 5, 2026 press release. It reports no new results, so AIM's outlook is unchanged.

  2. Sep 14, 2026, 4:47 PM ET · Market

    AIM ImmunoTech Inc. has made a big deal with Streeterville Capital to trade about $400,000 in debt for stock.

    Neutral

    AIM converted about $400,000 of debt into 1,749,434 shares, cutting liabilities but increasing share count, so the filing leaves the company view unchanged.